Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Montpellier
Clinical trial register · France

Clinical Trials in Montpellier, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Montpellier169 AstraZeneca61 Institut du Cancer de Montpellier - Val d'Aurelle59 Novartis Pharmaceuticals32 Hoffmann-La Roche32
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Montpellier

1023 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Bron, Chambray-lès-Tours, Créteil, Marseille, Montpellier, Paris, Pessac, Poitiers
2027-11-23
Not yet open
Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone
NCT07613528Pregnancy, Progesterone Supplementation, Low Serum Progesterone
DrugsProgestan·Progesterone
University Hospital, Montpellier
Phase 3
214
Montpellier
2027-03
Not yet open
University Hospital, Clermont-Ferrand
Phase 4
240
Amiens, Avignon, Bayonne, Clermont-Ferrand, La Roche-sur-Yon, Montpellier, Nancy, Nîmes
2026-12-01
Not yet open
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
320
Avignon, Clermont-Ferrand, Grenoble, Le Puy-en-Velay, Lyon, Montpellier, Paris, Saint-Etienne
2026-12
Not yet open
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
NCT07814001Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Refractory Large B-cell Lymphoma (LBCL), Refractory T-cell/Histiocyte-rich Large B-cell Lymphoma, Refractory Transformed Follicular Lymphoma
DrugsEpcoritamab·Lenalidomide
The Lymphoma Academic Research Organisation
Phase 2
55
Créteil, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes
2026-12
Not yet open
University Hospital, Bordeaux
Not applicable
60
Bron, Caen, Lille, Limoges, Montpellier, Nîmes, Paris, Pessac
2026-11-01
Not yet open
University Hospital, Montpellier
Not applicable
6
Montpellier
2026-11
Not yet open
Diagnostic and Psychometric Validation of the FRENCH HELP Scale in Hyperemesis Gravidarum
NCT07767071Hyperemesis Gravidarum, Nausea and Vomiting of Pregnancy
Centre Hospitalier Universitaire de Nīmes
Observational
300
Alès, Béziers, Mende, Montpellier, Nîmes, Sète, Toulouse
2026-11
Not yet open
Poitiers University Hospital
Not applicable
778
Angers, Bayonne, La Roche-sur-Yon, La Rochelle, Montpellier, Nancy, Poitiers, Rennes
2026-11
Not yet open
FASTEN
Not applicable
144
Aix-en-Provence, Briis-sous-Forges, Lyon, Marseille, Montpellier, Neuilly-sur-Seine, Paris
2026-10-30
Not yet open
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
NCT07873931Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies
Bristol-Myers Squibb
Phase 1
60
Montpellier, Paris
2026-10-30
Not yet open
Nantes University Hospital
Not applicable
80
Ambon, Caen, Cugand, Éragny, Guidel, L'Île-Rousse, Lyon, Montpellier
2026-10-01
Not yet open
Centre Georges Francois Leclerc
Not applicable
18
Dijon, Montpellier, Rennes, Villejuif
2026-10-01
Not yet open
University Hospital, Montpellier
Phase 2
66
Montpellier
2026-10
Not yet open
Institut du Cancer de Montpellier - Val d'Aurelle
Observational
115
Montpellier
2026-10
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Saint-Herblain, Montpellier, Paris, Bordeaux, Dijon, Lyon, Marseille
2026-09-29
Recruiting
University Hospital, Montpellier
Not applicable
40
Montpellier
2026-09-23
Recruiting
Daiichi Sankyo
Phase 1/2
220
Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Nîmes
2026-09-17
Recruiting
AstraZeneca
Phase 3
1,330
Angers, Caen, Montpellier, Paris, Poitiers
2026-09-15
Recruiting
Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk
NCT07406516Patellar Tendinitis, Jumper's Knee, Musculoskeletal Injuries, Knee Injuries
University Hospital, Montpellier
Not applicable
60
Montpellier
2026-09-15
Not yet open
TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study
NCT07821008Subarachnoid Hemorrhage, Aneurysmal, Brain Ischemia, Endovascular Procedure
University Hospital, Toulouse
Phase 3
274
Bordeaux, Montpellier, Nantes, Paris, Strasbourg, Toulouse, Tours
2026-09-14
Recruiting
Bristol-Myers Squibb
Phase 2
160
Nice, Montpellier, Villejuif, Grenoble, Marseille, Paris, Saint-Herblain
2026-09-10
Not yet open
University Hospital, Toulouse
Phase 3
724
Bordeaux, Grenoble, Lille, Limoges, Marseille, Montpellier, Nantes, Paris
2026-09-01
Not yet open
Two Modalities of Ventilation on the Occurrence of Respiratory Complications During Inhalational Anaesthetic Induction in Children
NCT07767851Anaesthetic Induction, Respiratory Complications of Care, Pediatrics, Ventilation
Hospices Civils de Lyon
Not applicable
2,032
Lyon, Marseille, Montpellier, Nantes, Paris, Reims, Strasbourg, Toulouse
2026-09-01
Not yet open
University Hospital, Toulouse
Phase 2
25
Bordeaux, Montpellier, Paris, Toulouse
2026-09-01
Not yet open
Centre Hospitalier Universitaire de Nīmes
Observational
300
Limoges, Lyon, Montpellier, Nîmes, Paris, Vandœuvre-lès-Nancy
2026-09
Not yet open
University Hospital, Montpellier
Not applicable
16
Montpellier
2026-09
Not yet open
University Hospital, Montpellier
Not applicable
600
Béziers, Cabestany, Montpellier, Narbonne, Nîmes, Perpignan, Roujan, Saint-Georges-dOrques
2026-09
Not yet open
Centre Hospitalier Universitaire de Nīmes
Observational
82
Millau, Nîmes, Béziers, Montpellier
2026-09
Not yet open
University Hospital, Toulouse
Phase 3
70
Montpellier, Toulouse
2026-09
Not yet open
University Hospital, Montpellier
Not applicable
500
Montpellier
2026-09
Not yet open
Strengthening, Guidance, Health, Empowerment
NCT07788599HIV Infection, Syphilis, Gonorrhea Infection, Chlamydia Infection
University Hospital, Montpellier
Not applicable
200
Montpellier
2026-09
Not yet open
SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
NCT07241273Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Cancers, Oropharyngeal Carcinoma, Head and Neck
UNICANCER
Not applicable
128
Brest, Caen, Dijon, Le Havre, Lille, Montpellier, Paris, Rouen
2026-09
Not yet open
Hypersomnia in the Paediatric Population
NCT07766343Wakefulness Disorder, Narcolepsy, Idiopathic Hypersomnia
University Hospital, Montpellier
Not applicable
760
Montpellier
2026-09
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
96
Bordeaux, Montpellier
2026-08-28
Recruiting
AstraZeneca
Phase 3
7,000
Corbeil-Essonnes, Grenoble, La Rochelle, Laval, Le Puy-en-Velay, Lyon, Metz-Tessy, Montpellier
2026-08-21
Recruiting
Impact of Pre-operative Sarcopenia on Functional Recovery After Hip Arthroplasty in Older Adults
NCT07429955Sarcopenia in Elderly, Osteoarthritis (OA), Hip Fracture Surgeries
DrugBlood sampling
University Hospital, Montpellier
Not applicable
20
Montpellier
2026-08-17
Recruiting
Eli Lilly and Company
Phase 2
606
Brest, Cholet, Créteil, La Tronche, Lyon, Marseille, Montpellier, Paris
2026-08-07
Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
NCT07746895C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
DrugPegcetacoplan
Swedish Orphan Biovitrum
Phase 4
150
Bordeaux, Bron, Créteil, Lille, Marseille, Montpellier, Nantes, Paris
2026-08-05
Not yet open
University Hospital, Montpellier
Not applicable
60
Montpellier
2026-08-01
Not yet open
ARCAGY/ GINECO GROUP
Phase 1/2
43
Bordeaux, Caen, Dijon, Lyon, Marseille, Montpellier, Pierre-Bénite, Rennes
2026-08
Not yet open
University Hospital, Montpellier
Observational
200
Montpellier
2026-08
Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
230
Bron, Marseille, Montpellier, Nantes, Paris, Pessac, Suresnes
2026-07-24
Recruiting
AstraZeneca
Phase 3
915
Bordeaux, Montpellier, Paris, Pierre-Bénite, Poitiers, Strasbourg
2026-07-16
Recruiting
University Hospital, Montpellier
Not applicable
15
Montpellier
2026-07-13
Recruiting
Ipsen
Observational
30
Bron, Dijon, Le Kremlin-Bicêtre, Marseille, Montpellier, Paris, Toulouse, Villejuif
2026-07-10
Recruiting
Fondation Ildys
Observational
343
Caen, Giens, Lille, Lyon, Montpellier, Paris, Reims, Rennes
2026-07-09
Recruiting
LEOPARD Prospective Validation Cohort 1
NCT06723275Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
630
Clichy, Créteil, Montpellier, Paris
2026-07-07
Not yet open
University Hospital, Montpellier
Not applicable
42
Montpellier
2026-07-01
Not yet open
Hospices Civils de Lyon
Observational
279
Clermont-Ferrand, Lyon, Montpellier
2026-07-01
Not yet open
Jean-Paul Belgrado
Not applicable
110
Montpellier, Toulouse
2026-07-01
Not yet open
Jean-Paul Belgrado
Not applicable
98
Montpellier, Toulouse
2026-07-01
Not yet open
Effect of the MIROKI Companion Robot on Anxiety in Pediatric Radiotherapy
NCT07645950Pediatric Oncology, Radiotherapy, Parent
Institut du Cancer de Montpellier - Val d'Aurelle
Observational
6
Montpellier
2026-07
Recruiting
University Hospital, Montpellier
Phase 2
94
Bordeaux, Lyon, Montpellier, Paris, Poitiers, Toulouse
2026-06-25
Recruiting
Immun4Cure Cohort of Autoimmune Diseases
NCT07515638Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Healthy Adult Volunteers
University Hospital, Montpellier
Observational
500
Montpellier
2026-06-23
Recruiting
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
NCT07342608Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
MicroPort CRM
Not applicable
450
Annecy, Clermont-Ferrand, Grenoble, Montpellier, Rouen, Tours
2026-06-23
Recruiting
Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NCT07378072MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Nantes University Hospital
Not applicable
72
Angers, Bordeaux, Dijon, Lyon, Marseille, Montpellier, Nantes, Paris
2026-06-17
Recruiting
Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis
NCT06114667Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Hypercapnic Acidosis, Respiratory Failure With Hypercapnia
University Hospital, Montpellier
Not applicable
174
Montpellier, Nîmes, Poitiers
2026-06-16
Recruiting
University Hospital, Montpellier
Not applicable
10
Montpellier
2026-06-16
Recruiting
AstraZeneca
Phase 3
150
Angers, Bayonne, Bobigny, Caen, Chambray-lès-Tours, Grenoble, Montpellier, Nancy
2026-06-15
Not yet open
Liquid Biopsy in Early Colorectal Lesions
NCT07319104Colorectal Neoplasms, Precancerous Conditions, Adenocarcinoma of the Colon
University Hospital, Montpellier
Observational
1,000
Amiens, Bordeaux, Brest, Dijon, Limoges, Lyon, Montpellier, Nancy
2026-06-15
Recruiting
University Hospital, Montpellier
Phase 3
250
Montpellier
2026-06-15
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
132
Marseille, Montpellier, Tours
2026-06-12
Recruiting
University Hospital, Montpellier
Phase 2
6
Lille, Montpellier, Paris, Rouen
2026-06-11
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Angers, Brest, Bron, Montpellier, Nice, Paris, Rennes, Tours
2026-06-11
Recruiting
Pfizer
Phase 3
954
Saint-Herblain, Montpellier
2026-06-10
Not yet open
Sys2Diag
Observational
60
Montpellier
2026-06-09
Recruiting
Psychoeducation Program for Family Caregivers Coordinated by an APRN
NCT07041463First Episode Psychosis (FEP), Caregiver Burden, Nurse Practitioners, IMPACT OF A NEW PSYCHOEDUCATION PROGRAM COORDINATED BY AN ADVANCED PRACTICE NURSE ON THE BURDEN OF FAMILY CAREGIVERS OF PATIENTS WITH A FIRST PSYCHOTIC EPISODE
Hôpital le Vinatier
Not applicable
180
Bohars, Bron, La Rochelle, Montpellier, Nîmes
2026-06-05
Recruiting
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase 3
320
Bayonne, Bordeaux, Brest, Créteil, Grenoble, Levallois-Perret, Lorient, Montpellier
2026-06-05
Recruiting
Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder
NCT07337889Borderline Personality Disorder, Borderline Personality Disorder (BPD), Bipolar Disorder (BD)
University Hospital, Montpellier
Not applicable
194
Montpellier
2026-06-01
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
4
Nice, Bron, Montpellier
2026-06-01
Not yet open
FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot Study
NCT07668713Hidradenitis Suppurativa (HS), Fecal Microbiota Transplantation (FMT)
DrugFecal Microbiota Transplantation
University Hospital, Clermont-Ferrand
Phase 1
24
Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Rodez
2026-06-01
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
228
Montpellier
2026-06-01
Not yet open
University Hospital, Toulouse
Phase 2
117
Bordeaux, Montpellier, Toulouse
2026-06
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
108
Bron, Lille, Montpellier, Nancy, Nantes, Paris
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Amiens, Lyon, Montpellier, Nantes, Poitiers, Talence, Toulouse, Tours
2026-05-31
Recruiting
Clinique Saint Jean, France
Not applicable
500
Montpellier
2026-05-27
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Amiens, Besançon, Clichy, Le Kremlin-Bicêtre, Lille, Montpellier, Nantes, Nice
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Besançon, Clichy, Le Kremlin-Bicêtre, Lille, Montpellier, Nantes, Nice, Pessac
2026-05-22
Recruiting
Kite, A Gilead Company
Phase 3
550
Montpellier
2026-05-22
Recruiting
BeOne Medicines
Phase 3
1,056
Bordeaux, Marseille, Montpellier, Rennes, Villejuif
2026-05-22
Not yet open
Fatigue and Hearing Performance of Healthy Volunteers Acutely Exposed to Occupational Noise ( FATIGAUDIT)
NCT07604077D001305, Auditory Fatigue, Noise Exposure, Environmental Noise
University Hospital, Montpellier
Not applicable
40
Montpellier
2026-05-15
Recruiting
Ipsen
Phase 3
350
Lille, Lyon, Montpellier, Nantes, Paris, Toulouse, Villejuif
2026-05-14
Recruiting
Eli Lilly and Company
Phase 2
600
Brest, Montpellier, Plérin, Saint-Cloud, Villejuif
2026-05-13
Recruiting
AstraZeneca
Phase 3
59
Aix-en-Provence, Brest, Colmar, Gleizé, Grenoble, Lyon, Marseille, Montpellier
2026-05-05
Recruiting
Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet
NCT07007338Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism
Hospices Civils de Lyon
Observational
20
Bordeaux, Bron, Montpellier, Nice, Paris, Strasbourg
2026-04-29
Recruiting
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia
NCT06999096Dystonia, Movement Disorders, Combined Dystonia, Complex Dystonia
University Hospital, Strasbourg, France
Not applicable
150
Montpellier, Nancy, Paris, Strasbourg
2026-04-22
Recruiting
Alkermes, Inc.
Phase 3
176
Bordeaux, Lyon, Montpellier
2026-04-22
Recruiting
University Hospital, Bordeaux
Not applicable
230
Bordeaux, Clamart, Limoges, Montpellier
2026-04-17
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
650
Bordeaux, Brest, Montpellier, Paris, Pierre-Bénite, Rouen
2026-04-16
Recruiting
Mediar Therapeutics
Phase 2
85
La Tronche, Montpellier, Paris, Strasbourg, Toulouse, Vandœuvre-lès-Nancy
2026-04-16
Not yet open
University Hospital, Bordeaux
Phase 2
72
Besançon, Bordeaux, Limoges, Marseille, Montpellier, Nantes, Paris, Reims
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Brest, Dijon, Lille, Lyon, Marseille, Montpellier, Paris, Pessac
2026-04-09
Recruiting
University Hospital, Montpellier
Not applicable
7
Montpellier
2026-04-08
Recruiting
Hoffmann-La Roche
Phase 2
80
Lille, Lyon, Marseille, Montpellier, Toulouse
2026-04-07
Recruiting
Alkermes, Inc.
Phase 3
150
Bordeaux, Lyon, Montpellier
2026-04-06
Recruiting
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
NCT07428499Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE
ADARx Pharmaceuticals, Inc.
Phase 3
90
Nice, Tours, Montpellier, Paris
2026-04-02
Not yet open
Viromes in Infants Presenting With a Septic Syndrome
NCT07470541Fever, Viral Infection, Bacterial Infections
DrugBiological samples
University Hospital, Montpellier
Not applicable
130
Montpellier
2026-04-01
Not yet open
University Hospital, Montpellier
Not applicable
60
Montpellier
2026-04
Not yet open
Homeostatic Regulation of Sleep in Short Sleepers
NCT07584538Short Sleepers, Normal Sleepers, Idiopathic Hypersomnia Patients
DrugBlood sample
University Hospital, Montpellier
Not applicable
75
Montpellier
2026-04
Recruiting
Anesthesia Management in Endovascular Therapy for Ischemic Stroke - 2
NCT07235514Ischemic Stroke, Anterior Cerebral Circulation, General Anesthesia, Procedural Sedation
University Hospital, Clermont-Ferrand
Not applicable
958
Angers, Brest, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nantes
2026-03-24
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Angers, Marseille, Montpellier
2026-03-24
Recruiting
Nantes University Hospital
Not applicable
1,401
Nantes, Brest, Lyon, Montpellier, Paris, Saint-Etienne
2026-03-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Montpellier, Créteil
2026-03-18
Recruiting
University Hospital, Montpellier
Not applicable
200
Montpellier
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Pessac, La Tronche, Montpellier, Saint Priest En Jarez, Bobigny
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
850
Bordeaux, Lyon Cedex08, Dijon, Montpellier, Saint-Herblain, Toulouse, Lille, Villejuif
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
750
Nice, Pessac, Lille, Montpellier, La Tronche, Saint-Herblain, Toulouse, Villefranche-sur-Saône
2026-03-12
Recruiting
Hoffmann-La Roche
Phase 2
360
Strasbourg, Nîmes, Bordeaux, Toulouse, Montpellier, Saint-Herblain, Nancy, Clermont-Ferrand
2026-03-10
Active, closed
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Le Kremlin-Bicêtre, Montpellier, Nantes, Nice, Pau, Poitiers
2026-03-03
Not yet open
University Hospital, Montpellier
Observational
30
Montpellier
2026-03-01
Not yet open
IHU Strasbourg
Observational
300
Aix-en-Provence, Besançon, Échirolles, Lille, Lyon, Montpellier, Saint-Etienne, Sète
2026-03
Not yet open
University Hospital, Montpellier
Not applicable
10
Montpellier
2026-03
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 2/3
120
Bordeaux, Clermont-Ferrand, Clichy, Créteil, Grenoble, Limoges, Lyon, Montpellier
2026-02-26
Recruiting
Center Eugene Marquis
Phase 2
80
Grenoble, Lille, Marseille, Montpellier, Nice, Rennes
2026-02-25
Recruiting
University Hospital, Montpellier
Not applicable
25
Montpellier
2026-02-23
Not yet open
University Hospital, Brest
Not applicable
34
Brest, Montpellier, Saint-Clément-de-Rivière
2026-02-20
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
26
Montpellier
2026-02-18
Recruiting
Sleep Apnea Biomarkers and Adherence to Continuous Positive Airway Pressure
NCT07792746Obstructive Sleep Apnea (OSA), CPAP, Biomarkers for Prediction of OA Treatment Efficacy
Clinique du Millenaire
Observational
200
Montpellier
2026-02-18
Recruiting
Study and Modeling of Perforator Flap Vascularization
NCT07084740Reconstructive Surgery Using Pedicled Perforating or Free Perforating Flaps, Pelvic Eschar, Traumatic Pathology of the Lower and/or Upper Limb
University Hospital, Montpellier
Not applicable
20
Montpellier
2026-02-15
Recruiting
Pfizer
Phase 2/3
1,156
Montpellier, Paris, Epagny Metz-Tessy, Lyon
2026-02-11
Recruiting
GlaxoSmithKline
Phase 1/2
54
Montpellier
2026-02-10
Recruiting
University Hospital, Montpellier
Observational
419
Montpellier
2026-02-10
Recruiting
University Hospital, Grenoble
Not applicable
4
Montpellier, Nantes, Paris
2026-02-04
Recruiting
University Hospital, Montpellier
Not applicable
100
Montpellier
2026-02-04
Recruiting
Nantes University Hospital
Observational
1,000
Bordeaux, Brest, Clermont-Ferrand, Dijon, La Rochelle, Limoges, Montpellier, Nantes
2026-02-03
Recruiting
BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus
NCT07070089Pulsatile Tinnitus, Venous Sinus Stenosis
Sonorous NV, Inc
Not applicable
90
Bordeaux, Montpellier, Paris, Tours
2026-02-01
Not yet open
Persistence of Sensitization to Contrast Media
NCT07409051Contrast Media Allergy
University Hospital, Montpellier
Observational
100
Montpellier
2026-02
Active, closed
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
NCT07363720Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
DrugTAK-861
Takeda
Phase 3
98
Montpellier, Paris, Toulouse
2026-01-29
Recruiting
University Hospital, Montpellier
Not applicable
100
Montpellier
2026-01-28
Recruiting
AbbVie
Phase 2
165
Montpellier, Rennes, Bobigny
2026-01-23
Recruiting
BeOne Medicines
Phase 3
500
Bordeaux, ClermontFerrand, Le Mans, Lille, Lyon, Montpellier, Toulouse
2026-01-22
Recruiting
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
NCT06254248Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic Treatment
Assistance Publique - Hôpitaux de Paris
Phase 2
50
Clichy, Créteil, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2026-01-22
Active, closed
CSL Behring
Phase 2
84
Limoges, Marseille, Montpellier, Mulhouse, Pessac, Pierre-Bénite, Rennes, Saint-Brieuc
2026-01-22
Not yet open
Luspatercept in Patients Affected With Rare Inherited Anemias
NCT07331818Hereditary Red Blood Cell Disorder (Disorder)
DrugReblozyl
EuroBloodNet Association
Phase 2
45
Lille, Montpellier, Paris, Pessac
2026-01-15
Not yet open
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
120
Dijon, Montpellier, Rennes, Saint-Herblain, Lille, Villeurbanne, Rouen, Avignon
2026-01-15
Recruiting
Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup
NCT07441941Oligometastatic Lung Tumor, NSCLC (Non-small Cell Lung Cancer), SBRT
Institut du Cancer de Montpellier - Val d'Aurelle
Observational
190
Montpellier, Vandœuvre-lès-Nancy
2026-01-14
Recruiting
University Hospital, Montpellier
Observational
30
Montpellier
2026-01-13
Recruiting
University Hospital, Montpellier
Not applicable
40
Montpellier
2026-01-12
Recruiting
AbbVie
Phase 2/3
680
Epagny Metz Tessy, Dunkirk, Lille, Montpellier, Tours, Vannes, Pessac, Poitiers
2026-01-08
By invitation
Medtronic
Observational
2,000
Chambray-lès-Tours, La Tronche, Lille, Montpellier, Pessac, Rennes, Rouen, Toulouse
2026-01-07
Recruiting
Postoperative Complications of Ankle Arthroscopy
NCT07335133Ankle Injuries and Disorders, Surgery Complications
Clinique Saint Jean, France
Not applicable
150
Montpellier
2026-01-05
Recruiting
University Hospital, Montpellier
Not applicable
114
Montpellier, Reims, Toulouse
2026-01-05
Recruiting
Institut Curie
Not applicable
450
Avignon, Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Nîmes, Paris
2026-01-05
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Nice, Pessac, Caen, Dijon, Besançon, Brest, Toulouse, Montpellier
2026-01-02
Not yet open
University Hospital, Toulouse
Phase 2
50
Bordeaux, Dijon, Montpellier, Nantes, Toulouse
2026-01
Not yet open
Comparison of a 3-step Bonding System (Transbond™ XT) and a 2-step System (GC Ortho Connect™) on Demineralization Around Maxillary Orthodontic Brackets
NCT07355322Tooth Demineralization, White Spot Lesion, Demineralization, Orthodontic Appliance Complication
University Hospital, Montpellier
Not applicable
34
Montpellier
2026-01
Recruiting
AEF0217 in Participants With Down Syndrome
NCT07334912Down Syndrome (Trisomy 21)
Aelis Farma
Phase 2
188
Bordeaux, Lyon, Montpellier, Paris, Saint-Etienne
2025-12-22
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
75
Besançon, Dijon, Grenoble, Lyon, Montpellier, Paris, Rennes, Tours
2025-12-22
Recruiting
Eli Lilly and Company
Phase 3
800
Avignon, Besançon, Brest, Clermont-Ferrand, Dijon, Le Mans, Lyon, Montpellier
2025-12-22
Active, closed
Amgen
Phase 3
250
Angers, Bordeaux, Grenoble, Montpellier, Pierre-Bénite
2025-12-19
Recruiting
Centre Hospitalier Intercommunal Creteil
Phase 2
80
Bruges, Créteil, Marseille, Montpellier, Neuilly-sur-Seine
2025-12-17
Not yet open
Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers
NCT06950398Organ Transplantation, Liver Dysfunction, Liver Diseases
Rennes University Hospital
Phase 2
99
Clichy, Lyon, Montpellier, Rennes, Tours, Villejuif
2025-12-15
Not yet open
University Hospital, Bordeaux
Not applicable
53
Montpellier, Palavas-les-Flots, Paris, Talence
2025-12-15
Recruiting
Ascendis Pharma A/S
Phase 3
186
Angers, Le Kremlin-Bicêtre, Montpellier, Paris, Toulouse
2025-12-12
Recruiting
AbbVie
Phase 2/3
490
Marseille, Brest, Lille, Montpellier, Paris
2025-12-10
Recruiting
AstraZeneca
Phase 2
230
Lyon, Montpellier, Nantes, Nîmes, Paris, Tours
2025-12-10
Recruiting
Cystinosis and Mitochondrial Metabolism
NCT07319091Cystinosis, Native Kidney
Hospices Civils de Lyon
Not applicable
25
Bron, Lille, Lyon, Marseille, Montpellier, Paris, Vandœuvre-lès-Nancy
2025-12-08
Recruiting
Hoffmann-La Roche
Phase 2
160
Strasbourg, Marseille, Montpellier, Toulouse, Paris
2025-12-05
Recruiting
CAPTEUR PROTECT
Not applicable
194
Bron, Corbeil-Essonnes, Grenoble, Marseille, Montpellier, Toulouse
2025-12-05
Recruiting
Bristol-Myers Squibb
Phase 3
650
Toulouse, Villeurbanne, Lille, Limoges, Montpellier, Paris, Strasbourg
2025-12-02
Recruiting
University of Avignon
Observational
160
Avignon, Montpellier
2025-12-01
Not yet open
University Hospital, Toulouse
Not applicable
178
Bordeaux, Lille, Marseille, Montpellier, Paris, Quint-Fonsegrives, Toulouse
2025-12-01
Active, closed
University Hospital, Montpellier
Observational
250
Montpellier
2025-12-01
Not yet open
Assistance Publique Hopitaux De Marseille
Not applicable
272
Montpellier
2025-12-01
Not yet open
Early Intervention After Traumatic Exposure in Children and Adolescents
NCT07207018Post-traumatic Stress Disorder (PTSD)
University Hospital, Montpellier
Not applicable
140
Montpellier
2025-12
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Avignon, Bron, Créteil, Le Mans, Limoges, Lyon, Montpellier, Pierre-Bénite
2025-11-30
Not yet open
University Hospital, Montpellier
Not applicable
111
Montpellier
2025-11-30
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
50
Montpellier
2025-11-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Bordeaux, Suresnes, Montpellier, La Tronche, Nancy, Angers, Bayonne, Pierre-Bénite
2025-11-26
Recruiting
Hoffmann-La Roche
Phase 3
900
Marseille, Bron, Clermont-Ferrand, Créteil, La Tronche, Lille, Limoges, Montpellier
2025-11-24
Recruiting
Summit Therapeutics
Phase 3
600
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice, Paris
2025-11-18
Recruiting
University Hospital, Angers
Not applicable
20
Angers, Brest, Le Kremlin-Bicêtre, Montpellier, Nantes, Paris, Rennes, Tours
2025-11-16
Recruiting
UNICANCER
Phase 2/3
196
Bordeaux, Clichy, Dijon, Marseille, Montpellier, Nantes, Paris, Poitiers
2025-11-14
Recruiting
Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution
NCT07254013Bradycardia, Left Bundle Branch Area Pacing, Cardiac Resynchronisation Therapy (CRT), ECG
MicroPort CRM
Not applicable
55
Besançon, Clermont-Ferrand, Grenoble, Montpellier
2025-11-14
Recruiting
Echosens
Not applicable
389
Besançon, Montpellier, Orsay
2025-11-14
Recruiting
University Hospital, Bordeaux
Not applicable
100
Bordeaux, Montpellier, Paris
2025-11-13
Active, closed
Hoffmann-La Roche
Phase 3
1,060
Amiens Cedex1, Bordeaux, Bron, Limoges, Montpellier, Paris, Saint-Herblain, Strasbourg
2025-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Limoges, Ajaccio, Amiens, Clermont-Ferrand, Grenoble, Lille, Montpellier, Nancy
2025-11-11
Recruiting
Nantes University Hospital
Phase 3
478
Chambray-lès-Tours, Lille, Lyon, Marseille, Metz, Montpellier, Nantes, Paris
2025-11-07
Recruiting
AstraZeneca
Phase 2
435
Brest, Créteil, Marseille, Montpellier, Paris, Pessac, Strasbourg, Toulouse
2025-11-06
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
65
Nice, Nantes, Pierre-Bénite, Dijon, Lille, Marseille, Montpellier, Paris
2025-11-06
Recruiting
Takeda
Observational
10
Brest, Bordeaux, Montpellier, La Tronche, Créteil
2025-11-03
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Pierre-Bénite, Brest, Plérin, Besançon, Montpellier, Toulouse, Marseille, Bobigny
2025-11-03
Not yet open
Efficacy of Prostatic Arteries Embolization Using SQUIDPERI
NCT07255508Benign Prostate Hypertrophy(BPH)
Assistance Publique - Hôpitaux de Paris
Observational
100
Marseille, Montpellier, Paris, Strasbourg
2025-11
Not yet open
Assistance Publique - Hôpitaux de Paris
Not applicable
230
Corbeil-Essonnes, Lyon, Montpellier, Paris
2025-11
Recruiting
AstraZeneca
Phase 3
100
Clermont-Ferrand, La Roche-sur-Yon, Montpellier, Paris, Pierre-Bénite
2025-10-30
Recruiting
Comparison of Ultrasound Cerebral Perfusion Imaging With Routine Perfusion CT
NCT07324421Neuro ICU, Sub Arachnoid Hemorrhage, Neurological Complication, Cerebral Ischemia
Resolve Stroke
Not applicable
50
Montpellier
2025-10-25
Recruiting
Hoffmann-La Roche
Phase 3
600
Angers, Bobigny, Bron, Caen, Lyon, Montpellier, Nice, Paris
2025-10-24
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Lyon, Clermont-Ferrand, Dijon, Besançon, Toulouse, Saint-Cloud, Montpellier, Vandœuvre-lès-Nancy
2025-10-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
70
Angers, Bordeaux, Dijon, Lyon, Montpellier, Paris, Rouen, Strasbourg
2025-10-21
Recruiting
Institut Claudius Regaud
Not applicable
130
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-21
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
42
Amiens, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nice, Toulouse
2025-10-13
Recruiting
University Hospital, Montpellier
Not applicable
60
Montpellier
2025-10-10
Recruiting
Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
NCT07099443Chronic Lymphocytic Leukemia, BTK Degraders
Nantes University Hospital
Observational
60
Angers, Bordeaux, Clermont-Ferrand, La Roche-sur-Yon, Lyon, Marseille, Montpellier, Nancy
2025-10-09
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Angers, Bron, Dijon, Montpellier, Paris, Toulouse, Tours
2025-10-09
Recruiting
Bristol-Myers Squibb
Phase 3
424
Nice, Clermont-Ferrand, Marseille, Montpellier, Paris
2025-10-08
Recruiting
University Hospital, Montpellier
Observational
150
Montpellier
2025-10-07
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
70
Mougins, Montpellier
2025-10-07
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Montpellier, Paris, Saint-Herblain
2025-10-06
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bayonne, Clermont-Ferrand, Créteil, Échirolles, Lille, Montfermeil, Montpellier, Nantes
2025-10-03
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Chambray-lès-Tours, Montpellier, Nantes, Pessac, Poitiers
2025-10-03
Recruiting
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
NCT07425639Chronic Spontaneous Urticaria (CSU), Allergic Asthma
DrugOmalizumab
Celltrion HealthCare France
Observational
225
Montpellier
2025-10-02
Not yet open
University Hospital, Tours
Observational
234
Angers, Bourges, Bron, Clermont, Clermont-Ferrand, La Rochelle, Limoges, Montpellier
2025-10-02
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Bayonne, Clermont-Ferrand, Créteil, Échirolles, Lille, Limoges, Montfermeil, Montpellier
2025-10-01
Active, closed
Hospices Civils de Lyon
Phase 2
27
Angers, Bordeaux, Bron, Lille, Lyon, Marseille, Montpellier, Paris
2025-10-01
Recruiting
AstraZeneca
Phase 1/2
283
Lyon, Montpellier, Saint-Herblain, Suresnes, Villejuif
2025-10-01
Not yet open
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
NCT07060950Cancer, Lung Cancer, Non-Small Cell
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
620
Montpellier
2025-10
Not yet open
Evaluation of the LUSHA Digital Application for Children With ADHD - Feasibility Study
NCT07204873Attention Deficit Disorder With or Without Hyperactivity (ADHD), Children
University Hospital, Grenoble
Not applicable
80
Grenoble, Montpellier
2025-10
Recruiting
Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder
NCT07031817Bipolar Disorder (BD), Major Depressive Episode (MDE), Primary Care, Major Depression
University Hospital, Montpellier
Not applicable
623
Montpellier
2025-09-30
Recruiting
Alfasigma S.p.A.
Phase 3
80
Bron, Dijon, Lille, Montpellier, Rennes, Tours
2025-09-29
Recruiting
Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months
NCT06723717Ruptured Aneurysm of Intracranial Artery, SAH (Subarachnoid Hemorrhage), Delayed Cerebral Ischemia
DrugDornase Alfa
Fondation Ophtalmologique Adolphe de Rothschild
Phase 2
304
Grenoble, Lyon, Montpellier, Poitiers, Strasbourg, Suresnes
2025-09-26
Recruiting
University Hospital, Montpellier
Observational
300
Montpellier
2025-09-22
Recruiting
Sanofi
Phase 4
218
La Tronche, Lille, Lyon, Marseille, Montpellier, Pessac, Reims
2025-09-22
Recruiting
University Hospital, Montpellier
Not applicable
114
Montpellier, Reims, Toulouse
2025-09-19
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Clermont-Ferrand, Limoges, Montpellier, Nice, Paris, Tours
2025-09-17
Recruiting
Sanofi
Phase 3
942
Brest, La Tronche, Le Mans, Lyon, Montpellier, Pessac, Pontoise, Reims
2025-09-16
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
30
Montpellier, Nîmes
2025-09-15
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Bordeaux, Lyon, Dijon, Toulouse, Montpellier, Rennes, Saint-Herblain, Reims
2025-09-11
Recruiting
Clinique Saint Jean, France
Not applicable
300
Montpellier
2025-09-09
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Angers, Brest, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris
2025-09-08
Recruiting
University Hospital, Toulouse
Observational
200
Amiens, Lille, Lyon, Montpellier, Nantes, Nice, Rouen, Toulouse
2025-09-03
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
140
Lyon, Montpellier, Paris, Reims, Strasbourg, Villejuif
2025-09-03
Not yet open
University Hospital, Montpellier
Observational
20
Montpellier
2025-09-01
Recruiting
Understanding Cycles to Improve Women's Health
NCT07037082Woman of Reproductive Age, Socioeconomic Factors
University Hospital, Montpellier
Observational
320
Montpellier
2025-09-01
Not yet open
University Hospital, Montpellier
Not applicable
40
Montpellier
2025-09
Not yet open
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
750
Montpellier
2025-09
Not yet open
Efficacy of a Smartphone Suicide Prevention App
NCT07160465Suicide, Suicide Attempt
University Hospital, Montpellier
Not applicable
632
Montpellier
2025-09
Recruiting
Central Hospital, Nancy, France
Not applicable
103
Bron, La Tronche, Montpellier, Nantes, Paris, Pessac, Rennes, Rouen
2025-08-29
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Nice, Tours, Grenoble, Montpellier, Paris
2025-08-28
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Angers, Besançon, Bobigny, Bordeaux, Caen, Lyon, Marseille, Montpellier
2025-08-26
Recruiting
AbbVie
Phase 1
36
Strasbourg, Montpellier
2025-08-26
Recruiting
AstraZeneca
Phase 3
700
Angers, Bordeaux, Caen, Clermont-Ferrand, Le Mans, Marseille, Montpellier, Nice
2025-08-06
Recruiting
Pfizer
Phase 3
400
Rennes, Brest, Saint-Cloud, Montpellier, Vandœuvre-lès-Nancy, Bron, Lyon, Pierre-Bénite
2025-08-05
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Angers, Bordeaux, Caen, Créteil, Grenoble, Lille, Lyon, Montpellier
2025-08-05
Not yet open
University Hospital, Montpellier
Not applicable
240
Montpellier
2025-08
Recruiting
Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement
NCT07666789Type 1 Diabetes (T1D), Islets of Langerhans Transplantation
University Hospital, Montpellier
Observational
20
Montpellier
2025-07-31
Active, closed
Vir Biotechnology, Inc.
Phase 3
150
Bobigny, Clichy, Créteil, Le Chesnay, Limoges, Lyon, Montpellier, Pessac
2025-07-30
Active, closed
Boehringer Ingelheim
Phase 1
16
Montpellier, Paris
2025-07-29
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 2/3
22
Bordeaux, Montpellier
2025-07-29
Recruiting
Celgene
Phase 3
400
Pessac, Saint-Cloud, Montpellier, Nantes, Lille, Pierre-Bénite, Paris, Toulouse
2025-07-28
Recruiting
Kiniksa Pharmaceuticals International, plc
Phase 2/3
325
Montpellier, Paris, Pessac, Poitiers, Toulouse
2025-07-25
Recruiting
Windward Bio
Phase 2
600
Pessac, Dijon, Montpellier, La Tronche, Nantes
2025-07-24
Recruiting
AbbVie
Phase 1/2
325
Montpellier, Poitiers, Toulouse, Nantes, Paris
2025-07-23
Recruiting
Pfizer
Phase 3
714
Pessac, Quimper, Toulouse, Rennes, Montpellier, Saint-Herblain, Cholet, Toulon
2025-07-23
Recruiting
Fluid-responsiveness Assessment Simplified by Electric Cardiometry in Children
NCT07522580Circulatory Failure, Shock State, Fluid Therapy
University Hospital, Bordeaux
Observational
42
Le Plessis-Robinson, Montpellier, Nantes, Pessac
2025-07-22
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Caen, Clichy, Lille, Lyon, Marseille, Montpellier, Nantes, Rennes
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
450
Nice, Clermont-Ferrand, Montpellier
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Angers, Bordeaux, Caen, Lyon, Marseille, Montpellier, Nantes, Paris
2025-07-17
Recruiting
Bristol-Myers Squibb
Phase 3
426
Toulouse, Villeurbanne, Lille, Limoges, Montpellier, Paris, Strasbourg
2025-07-16
Recruiting
Takeda
Phase 3
347
Créteil, Bordeaux, Limoges, Montpellier, Nantes, Paris
2025-07-15
Recruiting
Bristol-Myers Squibb
Phase 3
586
Nice, Toulouse, Rouen, Montpellier, Reims, Villeurbanne, Dijon
2025-07-14
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
89
Toulouse, Montpellier, Rennes, Strasbourg, Paris
2025-07-14
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA
Artiva Biotherapeutics, Inc.
Phase 2
90
Marseille, Montpellier, Toulouse
2025-07-09
Recruiting
Poitiers University Hospital
Not applicable
114
Garches, Montpellier, Poitiers, Rennes, Saint-Etienne, Toulouse
2025-07-09
Recruiting
University Hospital, Montpellier
Observational
80
Montpellier
2025-07-09
Active, closed
Sanofi
Phase 2
105
Lille, Montpellier, Nice, Pierre-Bénite, Saint-Priest-en-Jarez, Toulouse
2025-07-07
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Chambray-lès-Tours, Créteil, Dijon, La Tronche, Marseille, Martinique, Montpellier, Paris
2025-07-02
Not yet open
University Hospital, Montpellier
Observational
72
Montpellier
2025-07-01
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Marseille, Dijon, Saint-Cloud, Montpellier, Rennes, Pierre-Bénite, Amiens, Créteil
2025-06-30
Active, closed
Mundipharma Research Limited
Phase 2
60
Amiens, Lille, Montpellier, Pessac
2025-06-30
Recruiting
University Hospital, Montpellier
Not applicable
150
Montpellier
2025-06-30
Recruiting
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
NCT06711666Congenital Heart Disease, Cyanotic Congenital Heart Disease, d-Transposition of the Great Arteries, Hypoplastic Left Heart Syndrome
Institut National de la Santé Et de la Recherche Médicale, France
Observational
174
Marseille, Montpellier, Palavas-les-Flots, Paris, Pessac
2025-06-27
Recruiting
Eli Lilly and Company
Phase 3
290
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Rouen
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Saint-Priest-en-Jarez
2025-06-26
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Amiens, Béziers, Bron, Dijon, Lille, Montpellier, Nantes, Nice
2025-06-25
Active, closed
DBV Technologies
Phase 3
480
Angers, Bron, Lille, Montpellier, Vandœuvre-lès-Nancy
2025-06-24
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
86
Besançon, Bordeaux, Brest, Bron, Le Kremlin-Bicêtre, Lille, Montpellier, Strasbourg
2025-06-23
Recruiting
Pfizer
Phase 2
620
Montpellier, Saint-Herblain, Toulon, Grenoble
2025-06-19
Recruiting
Music Therapy During NIV Implantation in Pediatric Intensive Care Units
NCT06848218Acute Respiratory Failure (ARF), Non Invasive Ventilation (NIV)
University Hospital, Montpellier
Not applicable
88
Montpellier
2025-06-18
Recruiting
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT06934538Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
Brenus Pharma
Phase 1/2
90
Bordeaux, Dijon, Lyon, Montpellier, Poitiers, Villejuif
2025-06-17
Active, closed
AbbVie
Phase 3
573
Nice, Montpellier, Créteil, St-Priest-en-Jarez, Paris
2025-06-17
Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
NCT07038200Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1
DrugDel-brax
Avidity Biosciences, Inc.
Phase 3
200
Marseille, Montpellier, Nice, Paris
2025-06-10
Recruiting
Emercell SAS
Phase 1
10
Montpellier
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Amiens, Créteil, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2025-06-09
Active, closed
Biogen
Phase 3
255
Montpellier, Paris
2025-06-09
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Angers, Clermont-Ferrand, Lille, Marseille, Montpellier, Nice, Paris, Pierre-Bénite
2025-06-04
Recruiting
University Hospital, Grenoble
Observational
35
Lyon, Pierre-Bénite, Strasbourg, La Tronche, Montpellier, Toulouse, Paris
2025-06-04
Recruiting
Sanofi
Phase 2
99
Montpellier, Nice, Toulouse
2025-06-03
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
DrugsBemnifosbuvir-Ruzasvir·BEM/RZR·Sofosbuvir-Velpatasvir
Atea Pharmaceuticals, Inc.
Phase 3
880
Nice, Strasbourg, Clichy, Montpellier, Clermont-Ferrand, Créteil
2025-06-02
Recruiting
EG Labo
Observational
246
Amiens, Bayonne, Besançon, Brest, Montpellier, Nantes, Neuilly-sur-Seine, Pierre-Bénite
2025-06-02
Not yet open
Pilot Study of PEnile TRAnsplantation - Vascularized Composite Allografts
NCT06781606Adults with Traumatic Penile Severe Defects, Congenital Penile Defects, Micropenis
Hospices Civils de Lyon
Not applicable
3
Bordeaux, Lille, Lyon, Marseille, Montpellier, Pierre-Bénite, Suresnes, Toulouse
2025-06-01
Not yet open
University Hospital, Bordeaux
Not applicable
20
Montpellier, Pessac
2025-06-01
Not yet open
Centre Hospitalier Universitaire de Nīmes
Not applicable
425
Montpellier, Lyon
2025-06-01
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
DrugOctreotide LAR
Novartis Pharmaceuticals
Phase 3
240
Bron, Clichy, Montpellier, Nantes, Pessac, Toulouse
2025-05-30
Not yet open
University Hospital, Montpellier
Not applicable
50
Montpellier
2025-05-30
Recruiting
EURO-STIM Registry
NCT06971796Obstructive Sleep Apnea, Obstructive Sleep Apnea (OSA)
Inspire Medical Systems, Inc.
Observational
1,000
Angers, La Tronche, Lille, Marseille, Montpellier, Saint-Priest-en-Jarez
2025-05-26
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bordeaux, Brest, Caen, Carassonne, Dijon, Lille, Lyon, Montpellier
2025-05-22
Active, closed
Alkermes, Inc.
Phase 2
126
Bordeaux, Montpellier, Grenoble
2025-05-22
Recruiting
CLUBE (UBE Stability / Dynamic Radio)
NCT06904326Spinal Instability
Clinique Saint Jean, France
Not applicable
400
Montpellier
2025-05-22
Recruiting
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
NCT06865651Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 2
44
Grenoble, Montpellier, Paris, Pierre-Bénite
2025-05-22
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Bordeaux, Marseille, Montpellier, Nantes, Paris, Rennes, Rouen
2025-05-21
Active, closed
Boehringer Ingelheim
Phase 1/2
5
Montpellier
2025-05-20
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Créteil, La Rochelle, La Tronche, Montpellier, Nantes, Paris, Toulouse
2025-05-19
Recruiting
SecuraBio
Phase 3
124
Rouen, Villejuif, Caen, Clermont-Ferrand, Montpellier, Nantes, Paris, Pessac
2025-05-19
Recruiting
University Hospital, Tours
Not applicable
140
Angers, Lille, Montpellier, Nantes, Orléans, Strasbourg, Tours
2025-05-16
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Angers, Bordeaux, Chambray-lès-Tours, Dijon, Lille, Lyon, Marseille, Montpellier
2025-05-15
Recruiting
Hoffmann-La Roche
Phase 3
425
Pierre-Bénite, Chambray-lès-Tours, Clermont-Ferrand, Créteil, La Roche-sur-Yon, Lille, Limoges, Montpellier
2025-05-12
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Strasbourg, Marseille, Montpellier, Rennes, La Tronche, Saint-Herblain, Léon, Lille
2025-05-06
Recruiting
Takeda
Phase 2
88
Montpellier, Paris
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Clichy, Lille, Lyon, Montpellier, Nantes, Nice, Pessac, Rennes
2025-05-06
Recruiting
Living With Guillain-Barré Syndrome as Children.
NCT06940908Guillain Barré Syndrome, Guillain-Barré Syndrome (GBS)
University Hospital, Toulouse
Observational
25
Montpellier, Toulouse
2025-05-05
Not yet open
University Hospital, Montpellier
Not applicable
300
Montpellier
2025-05-02
Recruiting
AstraZeneca
Phase 1
72
Bordeaux, Montpellier, Nancy, Paris, Strasbourg, Toulouse
2025-05-01
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Béziers, Cholet, Grenoble, Lille, Montpellier, Paris, Pessac, Poitiers
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
905
Caen, Corbeil-Essonnes, Le Creusot, Lyon, Marseille, Montpellier, Nantes, Pontoise
2025-04-25
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Mulhouse, Caen, Dijon, Brest, Montpellier, La Tronche, Angers, Vandœuvre-lès-Nancy
2025-04-24
Recruiting
Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
NCT06864481Liver Injury, Secondary to Immune Checkpoint Inhibitors, Cancer Patients
University Hospital, Montpellier
Observational
250
Montpellier
2025-04-22
Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NCT06512883Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
14
Lille, Montpellier
2025-04-17
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Nice, Montpellier, Saint-Herblain, Angers, Rouen, Le Kremlin-Bicêtre
2025-04-16
Not yet open
University Hospital, Montpellier
Observational
55
Montpellier
2025-04-15
Not yet open
University Hospital, Montpellier
Not applicable
30
Montpellier
2025-04-15
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
254
Dijon, Nîmes, Bordeaux, Montpellier, Angers, Lyon
2025-04-15
Recruiting
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002Immunology, Allergy, Genetic Diseases, Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France
Observational
500
Lille, Lyon, Montpellier, Paris, Tours
2025-04-09
Recruiting
Hoffmann-La Roche
Phase 3
450
Angers, Lille, Montpellier, Paris, Plérin, Poitiers, Rennes, Rouen
2025-04-09
Recruiting
Institut Claudius Regaud
Not applicable
150
Angers, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier, Nantes
2025-04-07
Recruiting
Vifor Pharma, Inc.
Phase 2
36
Montpellier, Paris, Toulouse
2025-04-06
Recruiting
University Hospital, Montpellier
Observational
5,400
Montpellier
2025-04-02
Active, closed
Merck Sharp & Dohme LLC
Phase 2
160
Caen, Montpellier, Villejuif, Paris
2025-04-01
Recruiting
University Hospital, Montpellier
Observational
700
Montpellier
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Nice, Paris
2025-04-01
Recruiting
Madeleine Bezault
Phase 2
80
Clermont-Ferrand, Créteil, Le Kremlin-Bicêtre, Lille, Lyon, Marseille, Montpellier, Nancy
2025-03-31
Recruiting
RapidPulse, Inc
Not applicable
170
Bordeaux, Montpellier, Toulouse
2025-03-27
Recruiting
AstraZeneca
Phase 3
600
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lyon, Montpellier, Nice, Paris
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
510
Avignon, Brest, Dijon, Montpellier, Paris, Poitiers, Rennes, Strasbourg
2025-03-27
Recruiting
Rennes University Hospital
Phase 4
400
Chambray-lès-Tours, Clichy, Lille, Lyon, Montpellier, Pessac, Rennes, Villejuif
2025-03-26
Recruiting
AstraZeneca
Phase 3
990
Brest, Lyon, Marseille, Montpellier, Paris, Pessac, Saint-Herblain
2025-03-25
Recruiting
Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
NCT07083089Mild Cognitive Impairment (MCI) Amnestic, Parkinson Disease (PD), Healthy Participants
Cilcare SAS
Not applicable
309
Montpellier, Nice, Nîmes, Villeurbanne
2025-03-24
Recruiting
Evaluation of Urinary Dysfunction in CANVAS Patients
NCT06817707Cerebellar Ataxia, Neuropathy, Vestibular Areflexia
Centre Hospitalier Universitaire de Nice
Not applicable
40
Nice, Montpellier, Lille
2025-03-21
Recruiting
UNICANCER
Phase 2
73
Amiens, Angers, Avignon, Besançon, Cholet, Dijon, Lyon, Montpellier
2025-03-21
Recruiting
Medtronic MiniMed, Inc.
Not applicable
40
Bordeaux, Corbeil-Essonnes, Lille, Montpellier, Nancy, Toulouse, Dijon, Marseille
2025-03-21
Recruiting
Daiichi Sankyo
Phase 3
582
Bordeaux, Dijon, Lille, Lyon, Montpellier, Nantes, Paris, Rennes
2025-03-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Lyon, Limoges, Montpellier, Saint-Herblain, Reims, Rouen, Toulon, Paris
2025-03-16
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Bordeaux, Grenoble, Lille, Lyon, Montpellier, Nancy, Paris, Perpignan
2025-03-14
Recruiting
Hospices Civils de Lyon
Not applicable
66
Annecy, Chambéry, Lyon, Montpellier, Nîmes, Toulouse
2025-03-14
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
25
Montpellier
2025-03-13
Active, closed
AstraZeneca
Phase 2
82
Montpellier, Poitiers, Saint-Priez En Jarez, Villejuif
2025-03-12
Recruiting
Centre Hospitalier Universitaire de Nīmes
Observational
120
Nîmes, Montpellier
2025-03-10
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
854
Montpellier
2025-03-06
Recruiting
AbbVie
Phase 1/2
252
Bordeaux, Saint-Herblain, Montpellier, Nice, Villejuif, Paris
2025-03-06
Recruiting
BeOne Medicines
Phase 3
300
Montpellier, Nantes, PierreBenite, Tours
2025-03-05
Recruiting
Hoffmann-La Roche
Phase 2
130
La Tronche, Montpellier, Pessac, Rennes, Tours
2025-03-05
Recruiting
GlaxoSmithKline
Phase 1/2
305
Lyon, Marseille, Montpellier, Pierre-Bénite, Villejuif
2025-03-04
Not yet open
University Hospital, Montpellier
Not applicable
183
Montpellier
2025-03-03
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
500
Montpellier
2025-03-01
Not yet open
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
NCT06604975Primary Polydipsia, Central Diabetes Insipidus, Nephrogenic Diabetes Insipidus
Assistance Publique Hopitaux De Marseille
Not applicable
155
Angers, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2025-03
Recruiting
Bayer
Phase 1
148
Montpellier, Bron, Nantes, Villejuif
2025-02-28
Recruiting
Daiichi Sankyo
Phase 3
726
Avignon, Brest, Dijon, Grenoble, Lille, Lyon, Montpellier, Nantes
2025-02-27
Recruiting
Bristol-Myers Squibb
Phase 3
530
Montpellier, La Tronche, Lille, Gleizé, Pierre-Bénite, Créteil, Villejuif, Marseille
2025-02-25
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Montpellier, Nancy, Rennes
2025-02-24
Recruiting
The Lymphoma Academic Research Organisation
Phase 2
100
Créteil, Dijon, Lille, Marseille, Montpellier, Nantes, Pierre-Bénite, Reims
2025-02-21
Recruiting
Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)
NCT06755008Pulmonary Disease, Chronic Obstructive
University Hospital, Montpellier
Not applicable
50
Montpellier
2025-02-19
Recruiting
Centre Hospitalier Universitaire de Nīmes
Observational
333
Clermont-Ferrand, Nîmes, Montpellier
2025-02-19
Recruiting
University Hospital, Montpellier
Observational
60
Montpellier
2025-02-14
Recruiting
Bayer
Phase 2
111
Pierre-Bénite, Brest, Lille, Bordeaux, Montpellier, Villejuif
2025-02-13
Recruiting
RAdiology Consultation Effectiveness
NCT06762665Radiology Interventional, Spinal Injections, Back Pain
University Hospital, Montpellier
Not applicable
270
Montpellier
2025-02-12
Recruiting
University Hospital, Montpellier
Observational
24
Montpellier
2025-02-10
Recruiting
Takeda
Phase 2
96
Montpellier, Nantes, Paris
2025-02-07
Recruiting
Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease
NCT05649514Neuropathology, Cognitive Decline, Sleep Disorder
University Hospital, Montpellier
Not applicable
50
Montpellier
2025-02-05
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Nice, Bordeaux, Lyon, Marseille, Caen, Montpellier, Villejuif, Paris
2025-02-04
Recruiting
Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
NCT06688968Alzheimer Disease, Early Onset, Parkinsons Disease with Dementia, Non Pharmacological Intervention
University Hospital, Montpellier
Not applicable
120
Montpellier
2025-02-04
Recruiting
University Hospital, Montpellier
Phase 2
200
Montpellier
2025-02-03
Not yet open
Institut Cancerologie de l'Ouest
Phase 2
114
Caen, Dijon, Lille, Limoges, Marseille, Montpellier, Paris, Pierre-Bénite
2025-02
Active, closed
Expectations of Patients in Palliative Situation
NCT06786897Acute Myeloid Leukemia
University Hospital, Montpellier
Observational
37
Montpellier
2025-01-31
Recruiting
AbbVie
Observational
1,200
Nice, Caluire-et-Cuire, Clermont-Ferrand, Échirolles, Besançon, Arras, Lille, Montpellier
2025-01-31
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Clermont-Ferrand, Montpellier, Paris, Saint-Cloud, Villejuif
2025-01-30
Active, closed
University Hospital, Montpellier
Observational
500
Montpellier
2025-01-30
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugALKS 2680
Alkermes, Inc.
Phase 2/3
786
Montpellier, Bordeaux
2025-01-27
Recruiting
ANRS, Emerging Infectious Diseases
Phase 3
610
Bordeaux, Montpellier, Nantes, Paris
2025-01-27
Recruiting
BeOne Medicines
Phase 1/2
258
Dijon, Montpellier, Toulouse
2025-01-23
Recruiting
Sys2Diag
Observational
66
Montpellier
2025-01-22
Recruiting
University Hospital, Montpellier
Not applicable
550
Montpellier, Nîmes
2025-01-20
Recruiting
Hospices Civils de Lyon
Observational
569
Bron, Montpellier, Strasbourg
2025-01-14
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
10
Nice, Montpellier
2025-01-09
Active, closed
Pfizer
Phase 3
1,035
Bayonne, Bordeaux, Lille, Saint-Cloud, Rennes, Montpellier, Saint-Herblain, Angers
2025-01-06
Not yet open
Cardiovascular Immaturity in Extremely Low Gestational Age Newborns: a Fundamental Prospective Study
NCT06737965ELGAN (22-28SA), Extremely Low Gestational Age Newborns, Cardiovascular Immaturity
University Hospital, Montpellier
Observational
15
Montpellier
2025-01-01
Recruiting
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
NCT03593317Arrhythmogenic Right Ventricular Dysplasia
DrugSpironolactone
Hospices Civils de Lyon
Phase 2
120
Amiens, Bron, Clermont-Ferrand, Dijon, Grenoble, Marseille, Montpellier, Nantes
2024-12-20
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
180
Caluire-et-Cuire, La Roche-sur-Yon, Lomme, Montpellier, Paris, Reims, Saint-Etienne, Tours
2024-12-19
Recruiting
Cytokinetics
Phase 3
1,800
Toulouse, Valenciennes, Rennes, La Tronche, Montpellier, Nantes, Bron, Toulon
2024-12-19
Recruiting
Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
NCT06618755Alcohol Use Disorder, Addiction, Alcohol Withdrawal, Motivational Interviews
University Hospital, Montpellier
Not applicable
104
Montpellier
2024-12-18
Recruiting
The PERSEVERE Study
NCT06588634Pulmonary Embolism, Pulmonary Thromboembolism
Inari Medical
Not applicable
200
Besançon, La Tronche, Montpellier, Nîmes, Paris
2024-12-16
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
55
Bordeaux, Clichy, Montpellier
2024-12-16
Recruiting
CUTISS AG
Phase 3
70
Lyon, Marseille, Montpellier
2024-12-13
Recruiting
Centre Hospitalier Universitaire de Nīmes
Observational
32
Montpellier, Nice, Nîmes, Toulouse
2024-12-12
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Bron, Montpellier, Nancy, Rennes
2024-12-12
Recruiting
The Leeds Teaching Hospitals NHS Trust
Observational
550
Bordeaux, Brest, Créteil, Massy, Montpellier, Nîmes, Paris, Saint-Cyr-sur-Loire
2024-12-12
Recruiting
Hospices Civils de Lyon
Not applicable
722
Bron, Dijon, Montpellier, Nancy, Paris, Pessac, Rennes, Saint-Herblain
2024-12-12
Active, closed
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
NCT06627179Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind, Retinal Disease
Laboratoires Thea
Phase 2
81
Montpellier, Paris
2024-12-11
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Montpellier, Paris
2024-12-09
Recruiting
Ryvu Therapeutics SA
Phase 2
178
Le Mans, Lille, Limoges, Lyon, Montpellier, Paris, Pessac
2024-12-05
Recruiting
Natural History Study of Children With LAMA2-related Dystrophies
NCT06354790Merosin Deficient Congenital Muscular Dystrophy
Institut de Myologie, France
Observational
40
Garches, Lyon, Montpellier, Paris
2024-12-05
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Brest, Dijon, Le Kremlin-Bicêtre, Lille, Montpellier, Saint-Priest-en-Jarez, Strasbourg, Talence
2024-12-04
Active, closed
H. Lundbeck A/S
Phase 3
401
Rennes, Lille, Bordeaux, Montpellier, Toulouse, Marseille, Paris
2024-12-03
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Montpellier, Paris, Pierre-Bénite, Rouen
2024-11-27
Recruiting
National Registry of Cardioneuroablation in Recurrent Reflex Syncope
NCT06159764Syncope, Vasovagal, Bradycardia, Heart Arrest
University Hospital, Bordeaux
Observational
50
Bron, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris, Pessac, Rennes
2024-11-27
Recruiting
University Hospital, Montpellier
Not applicable
100
Nîmes, Montpellier
2024-11-27
Recruiting
TBF Genie Tissulaire
Phase 3
116
Brest, Lyon, Marseille, Montpellier, Nantes, Paris, Saint-Priest-en-Jarez, Strasbourg
2024-11-25
Active, closed
Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia
NCT07199179Depression - Major Depressive Disorder, Depression Disorder, Suicide
University Hospital, Montpellier
Observational
456
Montpellier
2024-11-24
Recruiting
ADDICTOlogical Intervention in LIVEr Transplantation Recipients
NCT06472973Alcohol Associated Liver Disease, Liver Transplantation
University Hospital, Montpellier
Not applicable
720
Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier
2024-11-21
Recruiting
Idorsia Pharmaceuticals Ltd.
Observational
785
Montpellier
2024-11-21
Recruiting
UCB Biopharma SRL
Phase 3
450
Bordeaux, Le Mans, Montpellier
2024-11-21
Recruiting
Biosency
Not applicable
380
Brest, Vannes, Le Coudray, Verdun, Lille, Montpellier, Toulouse, Marseille
2024-11-20
Recruiting
University Hospital, Montpellier
Observational
25
Montpellier
2024-11-19
Recruiting
University Hospital, Montpellier
Not applicable
42
Montpellier
2024-11-18
Not yet open
Postoperative Extubation in Hypoxemic Patients
NCT06688487Hypoxemia, Extubation, Postoperative Respiratory Complication
Fondation Hôpital Saint-Joseph
Not applicable
152
Argenteuil, Besançon, Le Plessis-Robinson, Montpellier, Paris, Reims, Saint-Denis
2024-11-18
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Rennes, Toulon, Bayonne, Grenoble, Montpellier, Paris
2024-11-18
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Angers, Bordeaux, Caen, Dijon, Montpellier, Nantes, Paris, Rennes
2024-11-15
Recruiting
One Year Pacing Dependency After TAVR
NCT06756282Patients Above 18 Years, Patient Discharge, Pacing Therapy, Aortic Stenosis (Treated With TAVI)
University Hospital, Montpellier
Observational
90
Montpellier
2024-11-13
Active, closed
argenx
Phase 2
87
Lille, Bordeaux, Marseille, Montpellier, Paris
2024-11-11
Recruiting
University Hospital, Montpellier
Not applicable
120
Montpellier
2024-11-08
Active, closed
Sanofi
Phase 2
556
Amiens, Lyon, Montpellier, Paris, Pessac, Strasbourg, Toulouse
2024-11-07
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
280
Montpellier, Nîmes
2024-11-06
Recruiting
University Hospital, Montpellier
Observational
160
Montpellier
2024-11-05
Recruiting
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Observational
100
Paris, Caen, Lyon, Marseille, Montpellier, Nîmes, Rennes, Strasbourg
2024-11-01
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
220
Le Kremlin-Bicêtre, Amiens, Lille, Limoges, Marseille, Montpellier, Nice, Paris
2024-10-31
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Bordeaux, Dijon, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2024-10-29
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
NCT06625775Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors
DrugsBBO-10203·Ribociclib·Folfox·Fulvestrant
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
392
Montpellier, Saint-Cloud, Saint-Herblain, Bordeaux, Lyon, Villejuif
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Angers, Brest, Clamart, Grenoble, Montpellier, Nice, Pessac, Poitiers
2024-10-24
Recruiting
University Hospital, Montpellier
Not applicable
20
Montpellier
2024-10-18
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Avignon, Lille, Lyon, Montpellier, Nantes, Paris, Pessac, Poitiers
2024-10-18
Recruiting
Perioperative Hemostasis Management in Liver Transplantation
NCT06257407Liver Transplant; Complications
Société Française d'Anesthésie et de Réanimation
Observational
1,200
Besançon, Clermont, Clichy, Grenoble, Lille, Lyon, Marseille, Montpellier
2024-10-17
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
600
Caluire-et-Cuire, Montpellier, Narbonne, Nice, Rouen, Tours
2024-10-15
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
960
Cahors, Caluire-et-Cuire, Échirolles, Montpellier, Narbonne, Nice, Rouen, Tours
2024-10-15
Active, closed
Mumming
Not applicable
88
Boulogne-Billancourt, Coutances, Grandchamps-des-Fontaines, Marseille, Montpellier, Paris, Ronchin, Rouen
2024-10-10
Active, closed
Novartis Pharmaceuticals
Phase 2
201
Dijon, Le Mans, Lille, Montpellier, Paris, Rennes, Strasbourg, Toulouse
2024-10-09
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Dijon, Brest, Toulouse, Montpellier, Rennes, Vandœuvre-lès-Nancy, Lille, Le Mans
2024-10-07
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bordeaux, Lyon, Montpellier, Nantes, Paris, Rouen
2024-10-05
Active, closed
AstraZeneca
Phase 3
768
Bordeaux, Caen, Lille, Montpellier, Nantes, Paris, Pessac, Toulon Armees
2024-10-04
Recruiting
University Hospital, Montpellier
Observational
200
Montpellier
2024-10-03
Active, closed
AstraZeneca
Phase 3
310
Créteil, La Tronche, Lyon, Marseille, Montpellier, Strasbourg
2024-09-30
Recruiting
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
NCT05486884Cardiac Arrest, Out-of-hospital Cardiac Arrest (OHCA)
Centre Hospitalier le Mans
Not applicable
1,380
Montpellier, Brest, Brive-la-Gaillarde, Caen, Cannes, Cholet, Dieppe, Dijon
2024-09-28
Recruiting
GlaxoSmithKline
Phase 2
393
Angers, Bobigny, Créteil, Lille, Montpellier, Rouen
2024-09-27
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Besançon, Nice, Strasbourg, Grenoble, Valenciennes, Montpellier, Chambray-lès-Tours, Limoges
2024-09-27
Recruiting
Egle Therapeutics
Phase 1/2
50
Dijon, Montpellier, Paris
2024-09-27
Active, closed
Merus B.V.
Phase 3
699
Bordeaux, Le Mans, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2024-09-25
Active, closed
Hoffmann-La Roche
Phase 3
338
Brest, Bron, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2024-09-23
Active, closed
Cerevance
Phase 3
330
Bron, Toulouse, Montpellier, Lille, Créteil
2024-09-20
Recruiting
University Hospital, Montpellier
Observational
76
Montpellier
2024-09-17
Recruiting
University Hospital, Limoges
Not applicable
1,000
Lille, Limoges, Marseille, Montpellier, Nice, Paris, Tours
2024-09-17
Active, closed
GlaxoSmithKline
Phase 2
153
Marseille, Melun, Montpellier, Nantes, Paris
2024-09-17
Not yet open
University Hospital, Montpellier
Phase 2
60
Montpellier
2024-09-15
Recruiting
University Hospital, Montpellier
Not applicable
120
Montpellier
2024-09-12
Active, closed
Centre Leon Berard
Not applicable
240
Lyon, Montpellier, Paris, Saint-Cloud, Vandœuvre-lès-Nancy, Villejuif
2024-09-12
Active, closed
University Hospital, Montpellier
Not applicable
260
Montpellier
2024-09-11
Active, closed
Amgen
Phase 3
315
Bordeaux, Limoges, Marseille, Montpellier, Nîmes, Toulon, Valenciennes, Vantoux
2024-09-09
Recruiting
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
NCT06370182Acute Ischemic Stroke From Large Vessel Occlusion
Anaconda Biomed S.L.
Not applicable
327
Montpellier, Paris, Suresnes, Toulouse
2024-09-09
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Bordeaux, Clermont-Ferrand, Marseille, Montpellier, Nantes, Paris, Strasbourg, Toulouse
2024-09-04
Recruiting
AbbVie
Phase 2
590
Nice, Montpellier, Rennes, Vandœuvre-lès-Nancy, Pessac, Toulouse, St-Priest-en-Jarez, Pierre-Bénite
2024-09-04
Not yet open
Stopping Pneumonia Antibiotherapy Regimen Early
NCT06291012Community-acquired Pneumonia, Child, Only
University Hospital, Montpellier
Phase 4
1,100
Montpellier
2024-09-01
Recruiting
Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach
NCT06915649Hippocampal Sclerosis, Dysembryoplastic Neuroepithelial Tumor, Cortical Dysplasia, Ganglioglioma
University Hospital, Montpellier
Observational
3,504
Montpellier
2024-08-31
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Montpellier, Pierre-Bénite
2024-08-28
Active, closed
AstraZeneca
Phase 2
194
Bois-Guillaume, Caen, Dijon, Montpellier
2024-08-27
Recruiting
Self-Identification Program
NCT06183359Major Depressive Disorder, Third Wave Cognitive Behavioral Therapy
University Hospital, Montpellier
Not applicable
86
Montpellier
2024-08-27
Active, closed
Kite, A Gilead Company
Phase 3
452
Lille, Marseille, Montpellier, Nantes, Paris, Pierre-Bénite, Poitiers, Rennes
2024-08-23
Recruiting
University Hospital, Montpellier
Not applicable
200
Montpellier
2024-08-19
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Montpellier, Paris
2024-08-19
Recruiting
Jazz Pharmaceuticals
Phase 3
550
Bordeaux, Caen, Dijon, Le Mans, Lille, Marseille, Montpellier, Strasbourg
2024-08-13
Recruiting
AstraZeneca
Phase 3
620
Brest, Clichy, Dijon, Lille, Lyon, Marseille, Montpellier, Pessac
2024-08-12
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
264
Saint-Herblain, Vandœuvre-lès-Nancy, Lyon, Montpellier, Nice, Nîmes, Paris, Toulouse
2024-08-09
Recruiting
AstraZeneca
Phase 3
1,018
Bayonne, La Tronche, Lille, Montpellier, Saint-Cloud, Vandœuvre-lès-Nancy
2024-08-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Montpellier, Saint-Herblain, Bron
2024-08-05
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
30
Montpellier, Nîmes
2024-08-02
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Strasbourg, Dijon, Toulouse, Montpellier, Tours, Nancy, Lille, Lyon
2024-07-30
Recruiting
Hospices Civils de Lyon
Phase 4
140
Avignon, Bobigny, Créteil, Dijon, Lille, Limoges, Lyon, Montpellier
2024-07-30
Recruiting
University Hospital, Montpellier
Observational
400
Montpellier
2024-07-29
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
210
Bayonne, Bordeaux, La Rochelle, Les Sables-d'Olonne, Marseille, Montpellier, Nantes, Nice
2024-07-24
Recruiting
CellProthera
Observational
48
Mulhouse, Dijon, Massy, Montpellier, Pessac, Toulouse
2024-07-20
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
174
Auxerre, Besançon, Colmar, Dijon, Metz, Montbéliard, Montpellier, Reims
2024-07-19
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Toulouse, Besançon, Pessac, Brest, Clermont-Ferrand, Clichy, Créteil, Montpellier
2024-07-19
Recruiting
University Hospital, Montpellier
Observational
60
Montpellier
2024-07-17
Recruiting
Amgen
Phase 3
450
Clermont-Ferrand, Créteil, Dijon, Lyon, Montpellier, Nice, Paris, Pessac
2024-07-17
Recruiting
COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial
NCT06425614On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion
University Hospital, Bordeaux
Not applicable
570
Bordeaux, Bron, Montpellier, Nantes, Paris, Rennes, Strasbourg, Toulouse
2024-07-15
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Le Kremlin-Bicêtre, Lille, Marseille, Montpellier, Paris
2024-07-12
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
187
Montpellier, Amiens, Bordeaux, Lyon, Marseille, Nancy, Nîmes, Toulouse
2024-07-05
Not yet open
DIAMPARK
Not applicable
300
Angers, Bourg-en-Bresse, Caen, Clamart, Le Puy-en-Velay, Montpellier, Nice, Troyes
2024-07-01
Recruiting
Gérond'if
Observational
637
Paris, Nantes, Poitiers, Rouen, Montpellier, Toulouse, Amiens, Angers
2024-07-01
Active, closed
Merus B.V.
Phase 3
621
Bordeaux, Brest, Le Mans, Lille, Lyon, Marseille, Montpellier, Nice
2024-06-25
Recruiting
REmote COnditioning in Out-of-Hospital Cardiac Arrest
NCT06306625Out-Of-Hospital Cardiac Arrest
Hospices Civils de Lyon
Not applicable
220
Bron, Clermont-Ferrand, Dijon, La Tronche, Lyon, Marseille, Montpellier, Nîmes
2024-06-21
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Nice, Marseille, Montpellier, Rennes, Saint-Herblain, Paris, Bron, Lyon
2024-06-19
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
55
Montpellier
2024-06-18
Recruiting
National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis
NCT06356831Endometriosis, Cryotherapy Effect, Surgical, Radiology
Centre Hospitalier Intercommunal Creteil
Observational
300
Bordeau, Bordeaux, Clermont-Ferrand, Créteil, Lyon, Marseille, Montpellier, Nîmes
2024-06-15
Recruiting
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
NCT06271057Diffuse Large B-cell Lymphoma Refractory, Refractory Primary Mediastinal Large B-Cell Lymphoma, Refractory Transformed B-cell Non-Hodgkin Lymphoma, Refractory High Grade B-Cell Lymphoma
DrugGolcadomide
The Lymphoma Academic Research Organisation
Phase 2
65
Créteil, Dijon, La Tronche, Lille, Marseille, Montpellier, Nantes, Paris
2024-06-14
Recruiting
Sensorion
Observational
100
Montpellier
2024-06-14
Recruiting
Genomic Study of Cutis Tricolor
NCT06073171Pigmentary; Dermatosis
DrugBlood sample
University Hospital, Montpellier
Not applicable
10
Montpellier
2024-06-05
Active, closed
Amgen
Phase 3
563
Bordeaux, Brest, Créteil, Le Mans, Lyon, Marseille, Montpellier, Paris
2024-06-05
Active, closed
Evaluation of the Effect of Kefir Consumption
NCT07522372Emotion, Well-being
Sys2Diag
Observational
66
Montpellier
2024-06-04
Recruiting
University Hospital, Bordeaux
Not applicable
192
Paris, Montpellier, Palavas-les-Flots, Pessac
2024-06-03
Recruiting
University Hospital, Montpellier
Not applicable
270
Montpellier, Palavas-les-Flots, Pessac
2024-05-31
Active, closed
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification
DrugsELVN-002·Eribulin·Leucovorin·Trastuzumab
Enliven Therapeutics
Phase 1
275
Montpellier, Poitiers, Saint-Herblain, Strasbourg
2024-05-30
Recruiting
University Hospital, Montpellier
Not applicable
112
Angers, Montpellier, Paris, Tours
2024-05-29
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Bron, Montpellier, Nantes, Toulouse
2024-05-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Amiens, Clichy, Dijon, Limoges, Lyon, Montpellier, Nice, Paris
2024-05-24
Recruiting
Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers
NCT06408402SDH-Related Familial Paraganglioma, SDHx-Related Syndromes, SDH Gene Mutation, Environmental Exposure
Assistance Publique - Hôpitaux de Paris
Observational
1,300
Angers, Besançon, Bron, Caen, Grenoble, Lille, Marseille, Montpellier
2024-05-22
Recruiting
University Hospital, Montpellier
Not applicable
85
Montpellier
2024-05-22
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Montpellier, Paris, Toulouse
2024-05-21
Recruiting
Daiichi Sankyo
Phase 3
540
Avignon, Bordeaux, Créteil, Lille, Limoges, Lyon, Marseille, Montpellier
2024-05-21
Active, closed
Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk
NCT06204549Adverse Cardiac Event, Major Adverse Cardiac Events
University Hospital, Montpellier
Not applicable
70
Montpellier
2024-05-21
Active, closed
European Myeloma Network B.V.
Phase 2
50
La Roche-sur-Yon, Montpellier, Nantes, Poitiers, Tours
2024-05-14
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
235
Annecy, Bordeaux, Boulogne, Lyon, Marseille, Montpellier, Nantes, Nice
2024-05-02
By invitation
University Hospital, Caen
Observational
200
Angers, Caen, Grenoble, Lille, Lyon, Metz, Montpellier, Nîmes
2024-05-01
Rows per page Showing 1–500 of 1023
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/montpellier

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,023 of those studies with a site in Montpellier.

How many clinical trials are recruiting in Montpellier?

577 of the 1,023 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 90 have not yet opened recruitment, 346 are active but closed to new participants, and 10 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Montpellier), 1,023 studies
PhaseStudiesRecruitingShare
Phase 332713632%
Not applicable26718826.1%
Observational16111215.7%
Phase 21567315.2%
Phase 1/248294.7%
Phase 2/328212.7%
Phase 12192.1%
Phase 41591.5%

Most active sponsors

Lead sponsors with the most studies (Montpellier)
Lead sponsorStudiesRecruiting
University Hospital, Montpellier169122
AstraZeneca6124
Institut du Cancer de Montpellier - Val d'Aurelle5942
Hoffmann-La Roche3214
Novartis Pharmaceuticals3215
AbbVie239
Bristol-Myers Squibb2216
Centre Hospitalier Universitaire de Nīmes2217
Eli Lilly and Company215
Janssen Research & Development, LLC208
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.